The clinical need for clustered AChR cell-based assay testing of seronegative MG
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Neuroimmunology"
DOI: 10.1101/2022.03.07.22272014
Abstract: Trial eligibility in myasthenia gravis (MG) remains largely dependent on a positive autoantibody serostatus. This significantly hinders seronegative MG (SNMG) patients from receiving potentially beneficial new treatments. In a subset of SNMG patients, acetylcholine receptor… read more here.
Keywords: clustered achr; achr cell; cell based; clinical need ... See more keywords